Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Israel Vlodavsky

Showing results (11-20 of 291) with videos related to

Pageof 30
Sort By:
Advances in Experimental Medicine and Biology|April 11, 2020
Forty Years of Basic and Translational Heparanase ResearchIsrael Vlodavsky, Neta Ilan, Ralph D Sanderson
Pathophysiology of Haemostasis and Thrombosis|January 30, 2009
Non-anticoagulant heparins and inhibition of cancerBenito Casu, Israel Vlodavsky, Ralph D Sanderson
Seminars in Cancer Biology|July 13, 2010
Tumorigenic and adhesive properties of heparanaseFlonia Levy-Adam, Neta Ilan, Israel Vlodavsky
Biochemical Pharmacology|February 26, 2014
The potential of heparanase as a therapeutic target in cancerClaudio Pisano, Israel Vlodavsky, Neta Ilan, et al.
FEBS Letters|April 26, 2005
Heparanase processing by lysosomal/endosomal protein preparationEsti Cohen, Ruth Atzmon, Israel Vlodavsky, et al.
Human Vaccines & Immunotherapeutics|April 8, 2016
Heparanase and cancer progression: New directions, new promisesGil Arvatz, Marina Weissmann, Neta Ilan, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 7, 2017
Proteases and glycosidases on the surface of exosomes: Newly discovered mechanisms for extracellular remodelingRalph D Sanderson, Shyam K Bandari, Israel Vlodavsky
Oncotarget|January 11, 2019
Heparanase inhibitors restrain mesotheliomaMoshe Lapidot, Uri Barash, Israel Vlodavsky, et al.
Current Pharmaceutical Design|July 14, 2007
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfateIsrael Vlodavsky, Neta Ilan, Annamaria Naggi, et al.
Plos One|January 28, 2014
Heparanase interacts with resistin and augments its activityDaniela Novick, Sara Barak, Neta Ilan, et al.
Pageof 30

Showing results (11-20 of 291) with videos related to

Sort By:
Pageof 30
Advances in Experimental Medicine and Biology|April 11, 2020
Forty Years of Basic and Translational Heparanase ResearchIsrael Vlodavsky, Neta Ilan, Ralph D Sanderson
Pathophysiology of Haemostasis and Thrombosis|January 30, 2009
Non-anticoagulant heparins and inhibition of cancerBenito Casu, Israel Vlodavsky, Ralph D Sanderson
Seminars in Cancer Biology|July 13, 2010
Tumorigenic and adhesive properties of heparanaseFlonia Levy-Adam, Neta Ilan, Israel Vlodavsky
Biochemical Pharmacology|February 26, 2014
The potential of heparanase as a therapeutic target in cancerClaudio Pisano, Israel Vlodavsky, Neta Ilan, et al.
FEBS Letters|April 26, 2005
Heparanase processing by lysosomal/endosomal protein preparationEsti Cohen, Ruth Atzmon, Israel Vlodavsky, et al.
Human Vaccines & Immunotherapeutics|April 8, 2016
Heparanase and cancer progression: New directions, new promisesGil Arvatz, Marina Weissmann, Neta Ilan, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 7, 2017
Proteases and glycosidases on the surface of exosomes: Newly discovered mechanisms for extracellular remodelingRalph D Sanderson, Shyam K Bandari, Israel Vlodavsky
Oncotarget|January 11, 2019
Heparanase inhibitors restrain mesotheliomaMoshe Lapidot, Uri Barash, Israel Vlodavsky, et al.
Current Pharmaceutical Design|July 14, 2007
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfateIsrael Vlodavsky, Neta Ilan, Annamaria Naggi, et al.
Plos One|January 28, 2014
Heparanase interacts with resistin and augments its activityDaniela Novick, Sara Barak, Neta Ilan, et al.
Pageof 30